表紙
市場調查報告書

罕見疾病用醫藥品(OD)的全球市場的預測

Orphan Drugs Market Global Report 2020-30

出版商 The Business Research Company 商品編碼 931975
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
罕見疾病用醫藥品(OD)的全球市場的預測 Orphan Drugs Market Global Report 2020-30
出版日期: 2020年04月10日內容資訊: 英文
簡介

本報告提供全球罕見疾病用醫藥品(OD)市場調查,提供市場概要,各治療領域·流通管道·主要各地各國的市場規模的變化與預測(過去5年·今後10年份),市場佔有率,成長率,市場成長要素及阻礙因素分析,近幾年主要的合併·收購(M&A)趨勢,市場策略,成長的預測投資領域,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

第2章 市場特徵

第3章 市場規模與成長率

  • 市場規模(實際成果值)
    • 市場成長要素
    • 市場阻礙因素
  • 市場規模(預測值)
    • 市場成長要素
    • 市場阻礙因素

第4章 罕見疾病用醫藥品(OD)的全球市場:各市場區隔

  • 市場規模:各治療領域(實際成果值·預測值)
    • 癌症·腫瘤
    • 血液
    • 中樞神經系統
    • 內分泌系
    • 心血管
    • 呼吸系統
    • 免疫調節
  • 市場規模:各流通管道(實際成果值·預測值)
    • 醫院藥局
    • 零售藥局
    • 線上

第5章 罕見疾病用醫藥品(OD)市場分析:各地各國

  • 市場規模:各地區(實際成果值·預測值)
  • 市場規模:各國(實際成果值·預測值)

第6章 亞太地區的罕見疾病用醫藥品(OD)市場

  • 市場概要
  • 市場規模:各治療領域(實際成果值·預測值)

第7章 中國的罕見疾病用醫藥品(OD)市場

第8章 印度的罕見疾病用醫藥品(OD)市場

第9章 日本的罕見疾病用醫藥品(OD)市場

第10章 澳洲的罕見疾病用醫藥品(OD)市場

第11章 印尼的罕見疾病用醫藥品(OD)市場

第12章 韓國的罕見疾病用醫藥品(OD)市場

第13章 西歐的罕見疾病用醫藥品(OD)市場

第14章 英國的罕見疾病用醫藥品(OD)市場

第15章 德國的罕見疾病用醫藥品(OD)市場

第16章 法國的罕見疾病用醫藥品(OD)市場

第17章 東歐的罕見疾病用醫藥品(OD)市場

第18章 俄羅斯的罕見疾病用醫藥品(OD)市場

第19章 北美的罕見疾病用醫藥品(OD)市場

第20章 美國的罕見疾病用醫藥品(OD)市場

第21章 南美的罕見疾病用醫藥品(OD)市場

第22章 巴西的罕見疾病用醫藥品(OD)市場

第23章 中東的罕見疾病用醫藥品(OD)市場

第24章 非洲的罕見疾病用醫藥品(OD)市場

第25章 競爭情形和企業簡介

  • 競爭情形
  • 企業簡介
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • F. Hoffmann-La Roche Ltd
    • Amgen
    • Biogen

第26章 主要合併·收購(M&A)趨勢

第27章 市場趨勢與策略

第28章 市場展望與潛在性分析

第29章 附錄

目錄

‘Orphan Drugs Market Global Report 2020-30 ’ from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global orphan drugs market.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the orphan drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? ‘The Orphan Drugs market global report ’ from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider orphan drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The orphan drugs market section of the report gives context. It compares the orphan drugs market with other segments of the orphan drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, orphan drugs indicators comparison.

Scope:

Markets Covered: 1) By Therapy Area: Oncology; Blood; Central Nervous System; Endocrine; Cardiovascular; Respiratory; Immunomodulatory

2) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales

Companies Mentioned: Bristol-Myers Squibb Company; Celgene Corporation; F. Hoffmann-La Roche Ltd; Amgen; Biogen

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA and Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Orphan Drugs Market Characteristics

3. Orphan Drugs Market Size And Growth

  • 3.1. Global Orphan Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Orphan Drugs Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Orphan Drugs Market Segmentation

  • 4.1. Global Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oncology

Blood

Central Nervous System

Endocrine

Cardiovascular

Respiratory

Immunomodulatory

  • 4.2. Global Orphan Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacy

Retail Pharmacy

Online Sales

5. Orphan Drugs Market Regional And Country Analysis

  • 5.1. Global Orphan Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • 5.2. Global Orphan Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Orphan Drugs Market

  • 6.1. Asia-Pacific Orphan Drugs Market Overview
  • 6.2. Asia-Pacific Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Orphan Drugs Market

  • 7.1. China Orphan Drugs Market Overview
  • 7.2. China Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Orphan Drugs Market

  • 8.1. India Orphan Drugs Market Overview
  • 8.2. India Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Orphan Drugs Market

  • 9.1. Japan Orphan Drugs Market Overview
  • 9.2. Japan Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Orphan Drugs Market

  • 10.1. Australia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Orphan Drugs Market

  • 11.1. Indonesia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Orphan Drugs Market

  • 12.1. South Korea Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Orphan Drugs Market

  • 13.1. Western Europe Orphan Drugs Market Overview
  • 13.2. Western Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Orphan Drugs Market

  • 14.1. UK Orphan Drugs Market Overview
  • 14.2. UK Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Orphan Drugs Market

  • 15.1. Germany Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Orphan Drugs Market

  • 16.3. France Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Orphan Drugs Market

  • 17.1. Eastern Europe Orphan Drugs Market Overview
  • 17.2. Eastern Europe Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Orphan Drugs Market

  • 18.1. Russia Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Orphan Drugs Market

  • 19.1. North America Orphan Drugs Market Overview
  • 19.2. North America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Orphan Drugs Market

  • 20.1. USA Orphan Drugs Market Overview
  • 20.2. USA Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Orphan Drugs Market

  • 21.1. South America Orphan Drugs Market Overview
  • 21.2. South America Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Orphan Drugs Market

  • 22.1. Brazil Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Orphan Drugs Market

  • 23.1. Middle East Orphan Drugs Market Overview
  • 23.2. Middle East Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Orphan Drugs Market

  • 24.1. Africa Orphan Drugs Market Overview
  • 24.2. Africa Orphan Drugs Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Orphan Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Orphan Drugs Market Competitive Landscape
  • 25.2. Orphan Drugs Market Company Profiles
    • 25.2.1. Bristol-Myers Squibb Company
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. Celgene Corporation
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. F. Hoffmann-La Roche Ltd
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Amgen
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Biogen
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Orphan Drugs Market

27. Orphan Drugs Market Trends And Strategies

28. Orphan Drugs Market Future Outlook and Potential Analysis

29. Appendix

  • 29.1. Abbreviations
  • 29.2. Currencies
  • 29.3. Research Inquiries
  • 29.4. The Business Research Company
  • 29.5. Copyright And Disclaimer